Company Filing History:
Years Active: 1993-2008
Title: Deborra E Mullins: Pioneering Advances in Pharmaceutical Innovations
Introduction
Deborra E Mullins, an esteemed inventor based in New York, NY, has made notable contributions to the pharmaceutical field. With a focus on innovative compounds aimed at treating various medical conditions, her work exemplifies the intersection of science and invention. Deborra holds a total of two patents, showcasing her dedication to advancing medical therapies.
Latest Patents
Among her latest innovations, Deborra has developed Neuropeptide receptor modulators, which discloses novel receptor antagonists for NPY Y1. This invention provides methods for preparing these compounds and emphasizes their pharmaceutical compositions, with applications targeting obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes. Additionally, she holds a patent for inhibitors of platelet-derived growth factor (PDGF), presenting a method to inhibit its binding. This compound is pivotal in treating several conditions, including atherosclerosis, cancer, retinal detachment, pulmonary fibrosis, arthritis, psoriasis, glomerulonephritis, and restenosis following angioplasty or vascular surgery.
Career Highlights
Deborra E Mullins currently works with Schering Corporation, where her innovative spirit thrives. Her contributions to pharmaceutical research have underscored her role as a significant figure in biochemistry and medicine. Her patents highlight her commitment to developing treatments that address critical health challenges, and her expertise in this domain is complemented by her extensive research experience.
Collaborations
Throughout her career, Deborra has collaborated with accomplished colleagues, including John W Clader and Harry R Davis. These partnerships have facilitated the exchange of ideas and expertise, enhancing the quality and impact of her research.
Conclusion
Deborra E Mullins stands as a prominent inventor whose work in developing novel pharmaceutical compounds has the potential to transform treatment protocols for chronic diseases. Her dedication to innovation and collaboration exemplifies the critical role inventors play in advancing healthcare solutions, affirming her place within the medical and scientific communities.